Chemodenervation in Treatment of Upper Eyelid Retraction
作者:
Seyhan B. Özkan,
Deniz Can,
Meltem F. Söylev,
Aysu Karatay Arsan,
Sunay Duman,
期刊:
Ophthalmologica
(Karger Available online 1997)
卷期:
Volume 211,
issue 6
页码: 387-390
ISSN:0030-3755
年代: 1997
DOI:10.1159/000310837
出版商: S. Karger AG
关键词: Botulinum toxin A;Levator palpebrae superioris muscle;Thyroid-associated eye disease;Upper-eyelid retraction
数据来源: Karger
摘要:
Upper-eyelid retraction is a common sign of thyroid-associated eye disease (TAED), and these patients are highly bothered by the appearance of their eyes. In this study, botulinum toxin A (BTA) was injected into the levator palpebrae superioris muscle in 8 eyes of 4 patients in an attempt to control the abnormal elevation of the upper eyelid. BTA provided control of the upper-eyelid retraction, and the cosmetically acceptable effect lasted for 3–4 months. It was concluded that BTA is an effective method of treatment in this condition. Since it has a temporary effect, it can safely be used to provide relief of symptoms related to upper-eyelid retraction during unstabilized periods of TAED, which may last as long as several years in some patients.
点击下载:
PDF
(1701KB)
返 回